A single blood test taken today could tell you whether you're on a path toward Alzheimer's 25 years from now.
Researchers followed 2,766 women for up to a quarter of a century, tracking a biomarker called p-tau217: a protein that gets chemically tagged during the early stages of Alzheimer's disease, long before any symptoms appear.
Every standard deviation increase in p-tau217 was associated with a 3x increase in risk of developing dementia.
The highest quartile (top 25%) had 7x the risk of the lowest quartile (bottom 25%).
The relationship was stronger in women over 70 and in APOE4/4 carriers.
Women who already had elevated ptau217 were at an even higher risk of developing dementia if they were on HRT, specifically estrogen + progestin.
#ptau217HD #alzheimersHD #hrtHD #apoe4HD #dementiaHD #estrogenHD #progestinHD




